Skip to content

Hilar Cholangiocarcinoma Radical Resection with Combined Vascular Resection and Reconstruction versus Non-Vascular Reconstruction: A multicenter, prospective cohort study

Hilar Cholangiocarcinoma Radical Resection with Combined Vascular Resection and Reconstruction versus Non-Vascular Reconstruction: A multicenter, prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124741
Enrollment
Unknown
Registered
2026-05-17
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hilar Cholangiocarcinoma

Interventions

Observation group:None
Control group:None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Generally good preoperative condition without significant dysfunction of vital organs including the brain, heart, lung, kidney and others 2.Preoperative imaging demonstrates a hilar mass or intrahepatic cholangiocarcinoma invading the hepatic hilum 3.No primary malignant tumor in other systems and no distant metastasis 4.Surgical procedures are radical resection of hilar cholangiocarcinoma with combined vascular resection and reconstruction, and radical resection without vascular resection and reconstruction 5.Postoperative pathology confirms cholangiocarcinoma

Exclusion criteria

Exclusion criteria: 1.Presence of surgical contraindications such as widespread systemic metastasis 2.Eastern Cooperative Oncology Group (ECOG) performance status score = 3, unable to tolerate general anesthesia 3.Patients refusing surgical treatment 4.Involvement of secondary or higher branches of bilateral intrahepatic bile ducts 5.Intrahepatic dissemination, peritoneal metastasis, or distant organ metastasis 6.Concurrent involvement of both left and right portal vein branches or bilateral hepatic arteries, with residual liver blood supply unable to be restored by vascular reconstruction

Design outcomes

Primary

MeasureTime frame
Incidence of severe complications (Clavien?Dindo grade = IIIa) during the perioperative period;

Secondary

MeasureTime frame
Postoperative biliary leakage rate;Specific postoperative complications included pancreatic fistula, biliary fistula, gastrointestinal anastomotic leakage, intra-abdominal infection, and abdominal cavity Bleeding, pulmonary infection, incision infection, etc;All-cause mortality rates at 30 days and 90 days after the surgery;Intraoperative indicators: operation time, intraoperative blood loss, intraoperative blood transfusion rate;Postoperative recovery indicators included first exhaust time, first feeding time, postoperative hospital stay, ICU admission rate and length of stay.;Oncology indicators included R0 resection rate, number of lymph node dissection and number of positive lymph nodes;Long-term prognosis: disease-free survival (DFS), overall survival (OS);

Countries

China

Contacts

Public ContactZhang Wen

The First Affiliated Hospital of Guangxi Medical University

wenzgxmu@163.com+86 138 7810 8107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026